Clinical Trials for AMD: A BrightFocus Interview with Benjamin Kim, MD
A clinical trial at the University of Pennsylvania, supported by BrightFocus’ Macular Degeneration Research program, is testing whether alpha lipoic acid can slow down the growth of geographic atrophy, an advanced form of dry age-related macular degeneration.
Benjamin Kim, MD
Clinical Trials: Your Questions Answered
Clinical trials play a critical role in the development of new treatments and are the culmination of years, often decades, of work done by researchers to find ways to slow, treat, or even cure macular degeneration. Unlike earlier phases of research, clinical trials are completely dependent on the volunteer participation of patients and others who are personally invested in seeing new treatments become available.
Explore Macular Degeneration Clinical Trials with Antidote
Are you thinking you may wish to participate in a macular degeneration clinical trial, but you aren’t sure how to get started? BrightFocus Foundation and Antidote – a third-party clinical trial matching service – have teamed up to make it easier to search for and find a clinical trial that is right for you. Based on your response to a few questions, Antidote’s smart search engine quickly and easily finds a trial in your area, one that meets other criteria for your search.
The first few weeks after a diagnosis can be overwhelming, and leave you with many questions and concerns.
If you are managing a new diagnosis, we have a Getting Started Guide that will help you understand and manage your disease.